CC BY-NC-ND 4.0 · Sleep Sci 2023; 16(02): 227-230
DOI: 10.1055/s-0043-1770799
Short Communication

Adherence to Positive Airway Pressure Therapy in a Cohort of Colombian Patients with Obstructive Sleep Apnea Syndrome

Judith L. Ortiz
1   Faculty of Economic and Administrative Sciences, Pontificia Universidad Javeriana, Bogota, DC, Colombia
,
Diego Rosselli
2   Clinical Epidemiology and Biostatistics Department, Pontificia Universidad Javeriana, Bogota, DC, Colombia
› Author Affiliations

Abstract

Objective To describe the adherence to the use of positive air pressure (PAP) devices in a cohort of patients with sleep apnea syndrome in Colombia.

Material and Methods Descriptive cross-sectional study of adult patients treated between January 2018 and December 2019 in the sleep clinic of a private insurer in Colombia.

Results The analysis included 12,538 patients (51.3% women) with a mean age of 61.3 years; 10,220 patients (81.5%) use CPAP and 1,550 (12.4%) BIPAP. Only 37% are adherent (> 70% of use for 4 hours or more), adherence rates were highest in the >65 years age groups. 2,305 patients (18.5%) were hospitalized, on average 3.2 times; 515 of these (21.3%) had one or more cardiovascular comorbidities.

Conclusion Adherence rates in this sample are lower than those reported elsewhere. They are similar in males and females and tend to improve with age.



Publication History

Article published online:
06 July 2023

© 2023. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Mulgrew AT, Ryan CF, Fleetham JA. et al. The impact of obstructive sleep apnea and daytime sleepiness on work limitation. Sleep Med 2007; 9 (01) 42-53
  • 2 Hidalgo-Martínez P, Lobelo R. Epidemiología mundial, latinoamericana y colombiana y mortalidad del síndrome de apnea-hipopnea obstructiva del sueño (SAHOS). Rev Fac Med (Caracas) 2017; 65 (Suppl 1): 17-20
  • 3 Cheung YY, Tai B-C, Loo G. et al. Obstructive sleep apnea and coronary risk in health screening clinic. J Am Coll Cardiol 2017; 69 (11) 1797
  • 4 Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG. Treatment of adult obstructive sleep apnea with positive airway pressure: An American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med 2019; 15 (02) 301-334
  • 5 Buyse B, Bruyneel M, Verbraecken J, Testelmans D. High adherence to continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA) in Belgium: a narrative review. Acta Clin Belg 2022; 77 (03) 710-720
  • 6 Molnar MZ, Mucsi I, Novak M. et al. Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans. Thorax 2015; 70 (09) 888-895
  • 7 Campo F, Sanabria-Arenas F, Hidalgo-Martínez P. Tratamiento del síndrome de apnea-hipopnea obstructiva del sueño (SAHOS) con presión positiva en la vía aérea (PAP). Rev Fac Med (Caracas) 2017; 65 (Suppl 1): 129-134
  • 8 Pépin JL, Tamisier R, Hwang D, Mereddy S, Parthasarathy S. Does remote monitoring change OSA management and CPAP adherence?. Respirology 2017; 22 (08) 1508-1517
  • 9 Peker Y, Glantz H, Eulenburg C, Wegscheider K, Herlitz J, Thunström E. Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea: The RICCADSA randomized controlled trial. Am J Respir Crit Care Med 2016; 194 (05) 613-620
  • 10 Chen J, Lin S, Zeng Y. An update on obstructive sleep apnea for atherosclerosis: Mechanism, diagnosis, and treatment. Front Cardiovasc Med 2021; 8: 647071
  • 11 Pachito DV, Bagattini ÂM, Drager LF, Eckeli AL, Rocha A. Economic evaluation of CPAP therapy for obstructive sleep apnea: a scoping review and evidence map. Sleep Breath 2022; 26 (01) 17-30 DOI: 10.1007/s11325-021-02362-8.
  • 12 Mello-Fujita L, Kim LJ, Palombini Lde O. et al. Treatment of obstructive sleep apnea syndrome associated with stroke. Sleep Med 2015; 16 (06) 691-696
  • 13 Gil-Rojas Y, Garzón A, Hernández F. et al. Burden of disease attributable to obesity and overweight in Colombia. Value Health Reg Issues 2019; 20: 66-72
  • 14 Benjafield AV, Ayas NT, Eastwood PR. et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 2019; 7 (08) 687-698
  • 15 Ercelik M, Balbay EG, Gulhan PY. et al. Factors affecting compliance with positive airway pressure therapy in obstructive sleep apnea. Sleep Breath 2022; 26 (02) 725-732
  • 16 Genzor S, Prasko J, Vanek J, Asswad AG, Nadjarpour S, Sova M. Adherence of obstructive sleep apnoea syndrome patients to positive airway pressure therapy: 10-year follow-up. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021
  • 17 Yang MC, Lin CY, Lan CC. et al. Factors affecting CPAP acceptance in elderly patients with obstructive sleep apnea in Taiwan. Respir Care 2013; 58 (09) 1504-1513
  • 18 Justo N, Espinoza MA, Ratto B. et al. Real-world evidence in healthcare decision making: Global trends and case studies from Latin America. Value Health 2019; 22 (06) 739-749